You searched for: xintela
Xintela carries out rights issue of SEK 72,8 million
Xintela reports clinical progress and strengthens collaborations
During the third quarter of 2025, Xintela took several important steps in the development of its stem cell and cancer programs. The company reported...
Xintela completes patient dosing in Phase I/IIa study
Focused investments in the cards for Flerie
Life science investor Flerie reports a net asset value of SEK 3,918 million at the end of the third quarter, equivalent to SEK 50,58...
Läkemedel
Premium
Many report decreased net asset value
Xintela's subsidiary initiates collaboration with Memorial Sloan Kettering
Xintela | Investing in Life Science 2025
CEO Evy Lundgren-Åkerlund presents Xintela at Investing in Life Science 2025.
Video
Xintela's XSTEM demonstrates safety and efficacy two years after knee osteoarthritis treatment
Xintela publishes half-yearly report
Peter Ekolind returns to Xintela
Xintela has recruited Peter Ekolind as new COO and Vice President Commercial Manufacturing. He has previously held several leading...
Xintela recruits Peter Ekolind as COO